Perioperative use of Angiotensin-Converting Enzyme (ACE) inhibitors/Angiotensin Receptor Blockers (ARBs) and beta-blockers were not associated with the development of HD in the present study, reinforcing the current recommendation for their perioperative maintenance. The gene discussed is ACE; the disease is Huntington disease.